HOME >> BIOLOGY >> NEWS
OneWorld Health CEO outlines mutually beneficial collaborations between industry, nonprofits at BIO

San Francisco, Calif. June 7, 2004 The economics and traditional structure of drug development are shifting in ways that could lead to viable markets for new, affordable drugs in the developing world if biopharmaceutical companies considered innovative collaborations with nonprofits, according to Victoria Hale, Ph.D., founder and CEO of the Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S.

Dr. Hale will speak at the BIO 2004 Annual International Convention in San Francisco as part of the Global Health track in a panel session titled "Mutually Inclusive: New and Affordable Drugs for Developed, Developing Worlds." The session will take place today, June 7, at 2:15 pm in the Moscone Convention Center, Room #2007 West.

Dr. Hale will speak about her company's proven record of collaboration that enables drug companies to partner without compromising their profitability goals. "The benefits of such collaborations are vast," stated Dr. Hale. "By working with us and other like-minded nonprofits, industry is an active partner in bringing new, affordable drugs to cure infectious diseases in the developing world, and helps to nurture new markets."

New advances in biotechnology manufacturing, splitting of intellectual property between partners to cover various geographies and indications, donations of promising but unused intellectual property, and sharing investments and risks in drug development are some of the strategies OneWorld Health uses to create collaborations with industry.

The most vital resource needed to achieve successful collaborations is people -- professionals with biopharmaceutical expertise. Dr. Hale said OneWorld Health will seek out companies that offer executive loan or sabbatical programs that would allow their employees to lend their talents to the nonprofit pharmaceutical company in specific programs.

The panel consists of:
Chair: Tom Brewer, Senior Project Offic
'"/>

Contact: Joanne Hasegawa
jhasegawa@oneworldhealth.org
415-421-4700
Institute for OneWorld Health
7-Jun-2004


Page: 1 2

Related biology news :

1. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
2. Institute for OneWorld Health nominated for the 2004 World Technology Awards
3. Institute for OneWorld Health receives Gates Foundation grant
4. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health
5. OneWorld Health completes enrollment, treatment in Phase III India trial
6. Institute for OneWorld Health CEO advocates focus first on developing world markets
7. OneWorld Health plans to form network of volunteer pharmaceutical scientists for global health
8. UC Santa Barbara donates discovery to OneWorld Health that may speed disease treatment
9. Victoria Hale of Institute for OneWorld Health Named Fellow by International Womens Forum
10. Health of worlds sea lions the focus of Wakefield Symposium
11. Healthy fats and oils essential to satisfy calorie-conscious consumers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/14/2019)... ... November 13, 2019 , ... NDA Partners Chairman ... regulatory affairs and program management executive with more than 33 years of regulatory ... the firm as an Expert Consultant. , Robert Peterson has extensive experience ...
(Date:11/12/2019)... Ohio (PRWEB) , ... November ... ... Products , a global leader in the design and manufacturer of technical ... of seating and adjustable footrests compliant with Healthier Hospital Initiative guidelines. Established ...
(Date:11/12/2019)... HAUPPAUGE, N.Y. (PRWEB) , ... November 12, 2019 ... ... made-in-the-USA germicidal ultraviolet air and water purifiers, announced today that distributors voted their ... ® and MEGATRON ® water purifiers. , The most frequent maintenance task ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... BELTSVILLE, Md. (PRWEB) , ... November 12, 2019 ... ... company has announced today that they have been selected by Lantern Pharma to ... collaboration is designed to obtain millions of data points using panels of unique ...
(Date:11/12/2019)... ... November 12, 2019 , ... Peggy ... Americans about the deadly healthcare-associated infection C. diff. The campaign, “See C. ... epidemic, which kills at least 30,000 people in the U.S. each year. The ...
(Date:11/5/2019)... , ... November 04, 2019 ... ... of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene ... cell line development technology, GPEx® Boost. The technology enhances Catalent’s proven GPEx ...
(Date:11/2/2019)... ... October 31, 2019 , ... Join ... in a live webinar on Friday, November 15, 2019 at 1pm ... Immunosequencing, the science of profiling T-cell receptors (TCRs) and B-cell receptors (BCRs), has ...
Breaking Biology Technology:
Cached News: